March 5, 2021 News by Marisa Wexler, MS #ACTRIMS2021 – Taking Medication During Pregnancy Reduces Healthcare Costs Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25–27. Go here to see the latest stories from the conference. Women with multiple sclerosis (MS) who continue taking disease-modifying therapies (DMTs) throughout pregnancy accrue lower non-maternity healthcare…
March 4, 2021 News by Forest Ray PhD #ACTRIMS2021 – Benign Versus Aggressive MS – the Hunt for Clues Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25–27. Go here to see the latest stories from the conference. While researchers make progress in pinpointing markers of disease progression in multiple sclerosis (MS), identifying those that signal…
March 4, 2021 News by Forest Ray PhD #ACTRIMS2021 – Cognitive, Without Physical, Disability Growing Concern in MS Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25–27. Go here to see the latest stories from the conference. Cognitive impairment without physical disability in multiple sclerosis (MS) may grow in prevalence as newer therapies better control…
March 3, 2021 News by Marisa Wexler, MS #ACTRIMS2021 – Reduced Methionine in Diet Eased Symptoms in MS Mice Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25–27. Go here to see the latest stories from the conference. Reducing the essential amino acid methionine in the diet lessened multiple sclerosis (MS)-like symptoms in a mouse model of…
March 3, 2021 News by Marisa Wexler, MS #ACTRIMS2021 – Dietary Restriction May Limit Severity of MS Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25–27. Go here to see the latest stories from the conference. Dietary restriction can lessen the severity of multiple sclerosis (MS) by modulating levels of fat-related hormones, new research…
March 3, 2021 News by Marisa Wexler, MS #ACTRIMS2021 – Research Finds Race- and Ethnicity-based Differences in MS Therapies Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25–27. Go here to see the latest stories from the conference. Clinical characteristics of multiple sclerosis (MS) patients, including their response to therapies, vary based on race and ethnicity,…
March 2, 2021 News by Forest Ray PhD #ACTRIMS2021 – COVID-19 Vaccines Safe for MS Patients, Minimally Affected by DMTs Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25–27. Go here to see all the latest stories from the conference. The currently approved COVID-19 vaccines pose little to no risk to people with multiple sclerosis (MS) and…
March 2, 2021 News by Forest Ray PhD #ACTRIMS2021 -MS Demographics in Latin America Broadly Similar to US, Europe Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25–27. Go here to see all the latest stories from the conference. The age of onset, sex, clinical features, and other demographic characteristics of multiple sclerosis (MS) in Latin…
March 2, 2021 News by Marisa Wexler, MS #ACTRIMS2021 – Leptin’s Pro-inflammatory Effects May Link Obesity to MS Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25–27. Go here to see all the latest stories from the conference. The fat-related hormone leptin has pro-inflammatory effects on immune cells, new data show, findings that help in better…
March 1, 2021 News by Forest Ray PhD #ACTRIMS2021 – Realities and Challenges of MS in Latin America Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25–27. Go here to see all the latest stories from the conference. Despite the overall low frequency of cases, multiple sclerosis (MS) in Latin America poses substantial socioeconomic challenges…
March 1, 2021 Columns by Ed Tobias MS News That Caught My Eye Last Week: POMS and Sunshine, Music Therapy, Tysabri, Socioeconomic Status Stories marked #ACTRIMS2021 are by members of the Multiple Sclerosis News Today team, who reported on this annual conference of MS researchers, held virtually this year due to COVID-19. #ACTRIMS2021 – 30 Minutes in Sun Each Day Lowers MS Risk in Children Can it really be this…
March 1, 2021 News by Marisa Wexler, MS #ACTRIMS2021 – Neurologist Calls for Trial Testing Estrogen Therapy at Menopause Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25–27. Go here to see all the latest stories from the conference. At the ACTRIMS Forum 2021, Rhonda Voskuhl, MD, a neurology professor at the University…
February 26, 2021 News by Marisa Wexler, MS #ACTRIMS2021 – Young Brain Fluid (CSF) Rejuvenates Memory in Mice Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25-27. Go here to see all the latest stories from the conference. Factors in the cerebrospinal fluid (CSF) surrounding the brain and spinal cord change with age and can affect…
February 26, 2021 News by Forest Ray PhD #ACTRIMS2021 – 30 Minutes in Sun Each Day Lowers MS Risk in Children Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25–27. Go here to see all the latest stories from the conference. Spending more time in the summer sun and living in generally sunnier places appears to provide protection against…
February 26, 2021 News by Forest Ray PhD #ACTRIMS2021 – Research Examines T-cells’ Anti-inflammatory Potential Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25–27. Go here to see the latest stories from the conference. Regulatory immune cells expressing the melanoma cell adhesion molecule (MCAM) dampen inflammation at sites of nerve damage in…
February 26, 2021 News by Forest Ray PhD #ACTRIMS2021 – Blood NFL Levels Seen to Rise With Markers of MS Progression Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25–27. Go here to see all the latest stories from the conference. Higher blood levels of neurofilament light chain (sNfL) were linked with disability, brain atrophy, and other features of…
February 25, 2021 News by Marisa Wexler, MS #ACTRIMS2021 – Better Strategies Needed to Help Socioeconomically Disadvantaged Patients Editor’s note: The Multiple Sclerosis News Today news team is providing in-depth and unparalleled coverage of the virtual ACTRIMS Forum 2021, Feb. 25-27. Go here to see all the latest stories from the conference. People with multiple sclerosis (MS) who are less socioeconomically advantaged tend to have faster rates…
February 23, 2021 News by Diana Campelo Delgado Johns Hopkins Neuroscientist Wins 2020 Barancik Prize for Innovation The 2020 Barancik Prize for Innovation in MS Research has been awarded to neuroscientist Dwight E. Bergles, PhD, a Johns Hopkins University professor, for his work in understanding the function of brain cells in multiple sclerosis (MS). This international prize awards $100,000 to the recipient. Administered by the National MS…
January 22, 2021 News by Marta Figueiredo, PhD #ACTRIMS2021 – Forum to Focus on Several MS-related Spectrums The upcoming Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2021 Forum will focus on the spectrums of multiple sclerosis (MS), related inflammation, disease severity, and the latest findings in the field. According to an ACTRIMS press release, about 1,000 researchers and clinicians are expected to…
